Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07407725 · ClinicalTrials.gov registry record · NA

Clinical Outcome Assessment for AT & BCI

A NA study of Spinal Cord Injury and ALS (Amyotrophic Lateral Sclerosis), sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07407725 is a NA study of Spinal Cord Injury and ALS (Amyotrophic Lateral Sclerosis) that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 60 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07407725, a NA study of Spinal Cord Injury and ALS (Amyotrophic Lateral Sclerosis), is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Many individuals with severe motor impairments rely on Assistive Technologies (ATs) or Brain-Computer Interfaces (BCIs) to interact with digital devices such as their computers. Clinicians and researchers currently lack a common framework to objectively quantify how much a given AT or BCI improves real-world function or to compare across tools. This project seeks to address this gap by developing a standardized method to objectively assess or compare the functional benefit of these tools on digital independence, i.e., the ability to independently operate computers, phones, and other digital systems, by creating a unique Digital Assessment Interface (DAI). This assessment will be a simulation of online and digital activities that prior work has determined is important to functional daily living in the digital domain. Participants will complete this assessment with various ATs and BCIs, and these scores will be used to create an index, which will be comprised of performance outcomes, clinician-reported outcomes, and patient-reported outcomes. The tool aims to quantify and compare digital task performance across devices and user populations. The primary objective of this study is to develop an index. The index will quantify functional performance of individuals using various ATs and BCIs. The secondary objectives are to extensively evaluate the psychometric properties of the index, such as the validity, responsiveness, reliability, and floor/ceiling effects both globally and across different devices and impairment levels, ensuring that it can reliably measure the impact of an AT or BCI on a user's ability to independently operate digital systems; and to characterize the familiarization and use of specific BCI and AT systems with reference to a normative healthy control population.

Conditions Studied

Spinal Cord Injury ALS (Amyotrophic Lateral Sclerosis)

Interventions

  • DEVICE Eye Tracker
  • DEVICE Mouth Operated Joystick
  • DEVICE Non-invasive electroencephalogram (EEG) Headset
  • DEVICE Implantable Brain-Computer-Interface
  • DEVICE Personal Assistive Technology

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-08
Est. Completion 2027-06
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07407725

The ClinicalTrials.gov registry entry for NCT07407725 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (30% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 5 interventions - of which Eye Tracker is the first listed.

NCT07407725 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07407725 about?

NCT07407725 is a clinical study titled "Clinical Outcome Assessment for AT & BCI". Many individuals with severe motor impairments rely on Assistive Technologies (ATs) or Brain-Computer Interfaces (BCIs) to interact with digital devices such as their computers. Clinicians and researchers currently lack a common framework to objectively quantify how much a given AT or BCI improves r...

What is the current status of trial NCT07407725?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-08. Estimated completion is 2027-06.

What conditions does trial NCT07407725 study?

This clinical trial studies the following conditions: Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis).

What interventions are being tested in trial NCT07407725?

The interventions under investigation include: Eye Tracker (DEVICE), Mouth Operated Joystick (DEVICE), Non-invasive electroencephalogram (EEG) Headset (DEVICE), Implantable Brain-Computer-Interface (DEVICE), Personal Assistive Technology (DEVICE).

Who is sponsoring clinical trial NCT07407725?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07407725 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spinal Cord Injury

All registered trials for this condition

ALS (Amyotrophic Lateral Sclerosis)

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.